Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems

BACKGROUND: Patients enrolled in clinical trials of advanced hepatocellular carcinoma (HCC) are usually required to have good liver reserve and organ function. However, their outcomes are still highly variable. We aimed to examine whether current staging systems can predict the survival of these hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Y-Y, Lu, L-C, Lin, Z-Z, Hsu, C, Shen, Y-C, Hsu, C-H, Cheng, A-L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493875/
https://www.ncbi.nlm.nih.gov/pubmed/23059748
http://dx.doi.org/10.1038/bjc.2012.466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493875/
https://www.ncbi.nlm.nih.gov/pubmed/23059748
http://dx.doi.org/10.1038/bjc.2012.466

Ejemplares similares